I’ll confirm the candidate SHA has not moved, then return one consistent final pass that resolves the earlier density vs slice-scope contradiction.# Conference Participant Output: ci-phase8-task81-native-pdf-visual-review - visual_single_object

## Boundary Check

- **Role:** `visual_single_object` (Codex chairs; no sub-venue chair). This is **same-session continuation round 3**, the corrected final pass for this role. It is not a new conference and not a new candidate.
- **Identity:** assigned `grok` / `grok-build` / `grok-4.6`; this session executed as **`cursor` / `cursor-grok-4.6`**. I am not a separate Grok Build CLI process and do not claim that route.
- **Candidate (unchanged this round):**
  - `output/pdf/native-pdf-vertical-slice.pdf` and `tmp/pdfs/native-pdf-vertical-slice.pdf` are the same bytes.
  - SHA-256 `b32d7c390ec3d456a5b47c63f996537c360ce7ac0bb3068784c624ed8e9cbbbe`
  - 4 pages; CreationDate `2026-08-31 01:34:27 +08`
- **Renders used:** `/tmp/ci-task81-visual-b32d7c39/page-{1-4}.png` from the prior same-session `pdftoppm -r 150` of this digest. Bytes did not change, so those images remain current. `runs/execution/ci-phase8-task81-native-pdf-slice/worker_03_evidence/renders` is still digest `31fc5add…` and is **not** current evidence (`track_pdf.md` §6).
- **Limits:** no Acrobat/Preview (no live bookmark-click, copy, or print-preview); `pdftotext` not on PATH (Chinese via `pypdf.extract_text()`); no registry lookup. **Not** final visual, clinical, or regulatory acceptance. Generator must not self-accept.
- **Hard boundaries:** read-only; no source edits; did not write `runs/conference/ci-phase8-task81-native-pdf-visual-review/visual_single_object.md`.
- **Round-3 purpose:** freeze one non-contradictory verdict. Earlier rounds flipped between “density is blocking,” “adequate with residuals,” and “must-fix list empty.” Those cannot stand together.

## Independent Work Product

### Contradictions resolved

| Earlier claim | Correction |
|---|---|
| Empty 50–90% bands **block** Task 8.1 visual_delivery | Too strong for the **slice PRD**. PRD visual evidence is no crop, overlap, black blocks, garbled CJK, isolated titles, or unreadable shrink. Those hold. |
| “Must-fix list is empty if D2 is residual” | Too strong for **this conference**. The objective still includes 信息密度. Empty bands are a real finding until Codex writes D2. |
| Put 24–28 AE rows on page 3 | Withdrawn. The fixture is 32 one-arm rows. 24+8 recreates a short tail. Filling both portrait pages needs more rows or a second arm (slice expansion). |
| `2026年7月31日` is a future dummy date | Wrong. Review date is 2026-08-31. Cutoff is prior. |
| `示例试验 01/02/03` is placeholder jargon that fails visual QA | Not a defect in this slice. `document.json` requires `示例试验 01` to be searchable. It is honest synthetic identity. |
| Cover bullet 3 “promises” a 52-week table that is missing | Wrong as a cover defect. Safety lives on pages 3–4 by page plan. |

**Stable dual verdict (this role, not Codex acceptance):**

1. **Task 8.1 listed PRD visual gates: met** on `b32d7c39…`.
2. **Conference 信息密度: open** until Codex writes D2. Empty portrait lower halves are the highest remaining visual *fact*. They are not a proven PRD fail, and they are not a density pass.
3. **Finished 竞品 PDF / full `track_pdf` reading file: not this artifact.**

### Candidate facts that stay closed

On `b32d7c39…` + the four SHA-bound 150 dpi pages:

- Portrait → landscape → portrait → portrait; A4 boxes.
- Bookmarks: `封面与摘要` → p1, `疗效比较` → p2, `安全性明细表` → p3.
- Footer on every page: `特应性皮炎创新药疗效与安全性比较 · 第 N 页`.
- On-page extract does **not** contain `垂直样例`, `snapshot`, `v-pdf-slice`, `同事实`, `NCT03985943`, `见页首`.
- Cover overview includes n/N: `56.2%（211/376）`, `18.7%（70/374）`, and siblings.
- Page 3 banner: `安全性明细 · 泰瑞奇单抗 · 试验 示例试验 01 · 治疗组 · 至第52周 · 安全性分析集`.
- Page 4: `续表 · … · 安全性分析集` with repeated headers `不良事件 / 发生率 / 例数`.
- Landscape: vector chart, no raster XObject; 治疗组 orange / 安慰剂 gray; labels `56.2 / 18.7 / 69.0 / 18.9 / 58.6 / 16.2` unclipped; chart above `第16周 EASI-75 完整数据表`; both arms on one view.
- Tf sizes: 8.5 / 9.5 / 10 / 11 / 12 / 13 / 18. No 9.0. Table/axis at 8.5 (allowed floor). Cover meta/captions at 9.5.
- CMS 康哲药业 wordmark on light ground; pale-orange headers with **dark** text; no risk-red; no garbled CJK; no footer/body overlap.

### Highest-impact remaining issue

**Portrait whitespace is real; its *class* is a chair decision, not a missing measurement.**

Non-white occupancy (SHA-bound 150 dpi):

- Page 1: bands 50–90% = 0.0% (content ends ~45%).
- Page 3: last body ~51%; bands 60–90% = 0.0%.
- Page 4: 16-row twin; 50–90% = 0.0%.

Cause: fixture cardinality (3 efficacy products; 32 one-arm AE rows at `rows_per_page=16`) plus a cover that is only a cover. This is not shrink-to-fit and not dropped clinical identity.

`track_pdf.md` §1 high density is the **full PDF track**. Task 8.1 `task.json` forbids expanding A/B/C templates. The conference still asked a medical manager to score 信息密度. Only Codex can say which lens binds.

### Remaining in-scope copy item

Quoted page-3 subtitle: `按发生率由高到低列示；治疗组、观察时间窗及分析人群在表题中标明。`

This is **true** after D6 (banner has 安全性分析集). It is still template language that explains how the page was assembled (`design.md`: 避免对工作流的解释). **Low severity, still in-scope.** Cheap fix: delete it, or replace with `治疗组至第52周不良事件，安全性分析集`.

### Recalibrated table

| ID | Finding | Class | Action |
|---|---|---|---|
| D2-empty | Portrait 50–90% empty | **Open classification** | Codex writes D2. Residual → accept slice with residuals. Blocking → grow fixture, do not 24+8. |
| S-caption | `在表题中标明` | Low, in-scope | Delete or replace before polish; not a clinical-identity miss |
| T-footer | Footer 8.5 pt | Residual / chrome | `FOOTER_PT = 8.5`; body floor is 9.5 |
| F-std | Helvetica/Times-Roman unembedded | Info | Visible CJK/ASCII on NotoSansSC |
| L-logo | 2420² raster logo, slightly soft | Low | Official mark present on light ground |
| D-cover-pop | 随机化人群 only on landscape | Residual | Cover already has n/N |
| — | `示例试验 01/02/03` | Not a defect | Fixture identity |
| — | `2026年7月31日` | Not a defect | Cutoff before review date |
| — | No heatmap / 95% CI / placebo AE | Out of slice | Full `track_pdf` §5 |

### Actionable path for Codex

**Do this now (process, no content change):**

1. Bind all visual evidence to `b32d7c39…`. Discard renders/text dumps from `31fc5add…` and `8da0c29b…`.
2. Open the pinned PDF in a native viewer: copy Chinese; search `泰瑞奇单抗`, `续表`, `示例试验`, `安全性分析集`; click the three bookmarks; flip portrait/landscape.

**Write one sentence (D2), then take exactly one branch:**

- **D2 = residual (recommended for Task 8.1 as specified):** Accept `b32d7c39…` as the Task 8.1 **vertical sample** with documented density residuals and optional S-caption polish. Do not grow the fixture in this task.
- **D2 = blocking (only if this conference is bound to full `track_pdf` density):** Grow the safety fixture (≥48 AE rows, or treatment + placebo), rebuild, re-pin SHA, re-run `pdftoppm`, then a same-session visual follow-up. Do not rebalance 16+16 into 24+8.

**Optional cheap edit (either branch):** remove `在表题中标明`. If bytes change, this role should re-inspect only the new SHA-bound page 3.

**Do not:** paste a 52-week safety teaser into the cover void; treat `worker_03` PASS notes as visual acceptance; promote this file as an A/B/C 阅读文件.

## Evidence And Assumptions

**Evidence**

- Re-hash this round: SHA `b32d7c390ec3d456a5b47c63f996537c360ce7ac0bb3068784c624ed8e9cbbbe`; tmp == output; 4 pages; title `特应性皮炎创新药疗效与安全性比较`.
- Extract: `见页首` absent; `在表题中标明` present; `安全性分析集` present; `211/376` on cover; `示例试验` present; banned snapshot/NCT/垂直样例/同事实 absent.
- Occupancy and chart/table visual QA from `/tmp/ci-task81-visual-b32d7c39` (valid because bytes did not change this round).
- `builder.py` still emits the layout-talk caption; `tokens.FOOTER_PT = 8.5`; `rows_per_page=16`.
- Fixture `document.json` page plan is cover / landscape efficacy / long safety table; searchable phrases include `示例试验 01`.
- Task 8.1 PRD visual checklist vs `track_pdf.md` §1 and conference objective “信息密度” remain two different bars.

**Inference**

- Codex already applied SHA pin, snapshot-string strip, synthetic trial IDs, cover n/N, and banner 分析人群. Density was left unwritten, not silently accepted.
- Empty paper is fixture size, not a typesetting failure.
- A medical manager who knows this is a 垂直样例 would pass readability and mark empty paper as ugly. A medical manager who thinks this is a finished 竞品 PDF would refuse on density. This conference invoked both; only the chair can pick the binding lens.

**Recommendation (this role only; not acceptance)**

- **Do not self-accept.**
- **Do not** call the must-fix list empty.
- **Do not** fail Task 8.1 PRD visual gates on empty paper unless D2 is written as blocking.
- Treat `b32d7c39…` as the only candidate.
- Preferred chair path: **D2 = residual**; accept as **slice with residuals**; optionally drop S-caption; rebind renders.
- Alternate chair path: **D2 = blocking** and grow the fixture.

**Uncertainty**

- D2 still has no chair sentence in the packet given to this role.
- Bookmark-click / select-copy in a native viewer still not exercised here.
- Exact CID glyph map beyond Tf + ASCII samples.
- `/Creator = ci_workflow.renderers.pdf_native` is metadata, not on-page.

## Risks, Gaps, And Verification Needs

- **False-accept risk:** using `worker_03_evidence/renders` (`31fc5add…`) as current pages.
- **Scope-collision risk:** accepting on the PRD crop/overlap list while the conference minutes say 信息密度 passed, or failing the slice on empty A4 without writing D2. Either is a process error.
- **Copy residual:** `在表题中标明` is a small user-visible template leak.
- **Verification Codex still owns:** native viewer pass; SHA-bound `pdftoppm`; written D2; footer 8.5 as chrome; logo provenance at print size.

### Objections, proposed solutions, decision points, questions

**Objections**

1. I will not treat empty 50–90% bands as a **proven** Task 8.1 PRD visual fail without written D2.
2. I will not treat those bands as a **density pass** for this conference until D2 is residual-in-writing.
3. I will not re-open `示例试验` or `2026年7月31日`.
4. I will not self-accept or call this a full 竞品 PDF.

**Proposed solutions:** write D2; rebind renders to `b32d7c39…`; optionally delete the page-3 layout-talk subtitle; grow fixture only on the blocking branch.

**Decision points**

- **D2 (binding):** empty cover/safety lower halves blocking for this conference, or residual for the slice?
- **S-caption:** required before accept, or polish?

**Bounded questions**

1. For `b32d7c39…`, answer D2 in one sentence. That sentence is the only remaining classification this role cannot make.
2. If you change bytes (S-caption or fixture growth), do you want a same-session follow-up on **new** SHA-bound renders only?

**Safe provisional path:** hold **final** visual acceptance. Keep `b32d7c39…` as the only candidate. Do not fail or pass density until D2 is written. Do not promote the file as a finished 阅读文件. Clinical identity on the long table and cover n/N are complete.

## Recommended Next Step

Codex should **write D2 for `b32d7c39…`**, replace stale execution renders with images of that digest, optionally delete `在表题中标明`, and then take one branch only: (a) accept Task 8.1 as a **vertical sample with documented density residuals**, or (b) expand the safety fixture if this conference is bound to full-track density. This role does not accept the file as a full medical 阅读文件, does not treat the PRD crop/overlap checklist as a density pass, and does not treat empty A4 bands as already closed.
